BioNTech SE (BNTX) Non-Current Debt (2018 - 2024)

BioNTech SE (BNTX) has 7 years of Non-Current Debt data on file, last reported at $50.1 million in Q4 2024.

• In Q4 2024, Non-Current Debt rose 20.05% year-over-year to $50.1 million; the TTM figure through Dec 2024 stood at $50.1 million (up 20.05% YoY), while the FY2024 annual figure was $50.1 million, up 20.05% from the prior year.
• Non-Current Debt improved to $50.1 million in Q4 2024, from $41.7 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $275.4 million in Q4 2020 and bottomed at $6.2 million in Q4 2022.
• A 5-year average of $115.4 million and a median of $50.1 million in 2024 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2022 — Non-Current Debt sank 96.94% — and 2023, when it surged 570.79%.
• Year by year, Non-Current Debt stood at $275.4 million in 2020, then slipped by 26.19% to $203.3 million in 2021, then sank by 96.94% to $6.2 million in 2022, then surged by 570.79% to $41.7 million in 2023, then increased by 20.05% to $50.1 million in 2024.
• The last three Non-Current Debt figures came in at $50.1 million (Q4 2024), $41.7 million (Q4 2023), and $6.2 million (Q4 2022), per Business Quant data.

Peer Comparison